Qiang ZHANG Qi-bao SHI Zhao-xin LIU Ming-min ZHANG. Clin Oncol Cancer Res (2010) 7: DOI /s
|
|
- Barbara Butler
- 6 years ago
- Views:
Transcription
1 DOI /s A Controlled Study on Comparing Differences in CT Perfusion Imaging between s inoculated with VX2 Lung Tumor and Patients with Squamous Cell Carcinoma of the Lung Qiang ZHANG Qi-bao SHI Zhao-xin LIU Ming-min ZHANG Department of Radiology, Inner Mongolia Baotou Tumor Hospital, Baotou , Inner Mongolia Autonomous Region, China. Correspondence to: Qiang ZHANG Tel: zhq @163.com Received November 19, 2010; accepted December 13, cocr@gmail.com Tel (Fax): OBJECTIVE By analysis and evaluation of the perfusion images and perfusion parameters of the rabbits with VX2 lung tumor, the association between the perfusion parameters and tumor angiogenesis of patients with squamous cell carcinoma of the lung has been studied in order to establish a non-invasive and effective way to detect tumor blood supply, which is be able to exhibit hemodynamic data in tumors during cancer treatments. METHODS Fifteen Netherlands rabbits inoculated with VX2 lung tumor (rabbit group) and 25 patients with squamous cell carcinoma of the lung (patient group) received a multi-slice spiral CT perfusion imaging test using the Netherlands PHILIPS Brilliance 16-slice spiral CT and a U.S. MEDRAD binocular highpressure syringe. Image postprocessing was done using the special perfusion software and EBW 4.0 Workstation. Perfusion volume (PV), peak enhanced increment (PEI), transit time peak (TTP), and blood volume (BV) were measured and analyzed. RESULTS In the rabbit group, the values of the PV, PEI, TTP, and BV of the tumor margin were (53.89 ± 13.38) ml/(min ml), (45.71 ± 15.52) Hu, (39.29 ± 10.10) sec, and (31.45 ± 18.19) ml/100 g, respectively; these values of the tumor center were (36.57 ± 14.17) ml/(min ml), (28.64 ± 11.74) Hu, (39.00 ± 9.78) sec, and (19.76 ± 13.95) ml/100 g, respectively; the values of the muscles were (12.45 ± 4.38) ml/(min ml), (10.98 ± 5.03) Hu, (38.86 ± 10.04) sec, and (5.38 ± 2.87) ml/100 g, respectively. The values of the relative perfusion volume (RPV), relative peak enhanced increment (RPEI), and relative blood volume (RBV) of the tumor margin were 4.38 ± 1.45, 3.96 ± 1.45, 9.99 ± 11.7, respectively; these values of the tumor center were 2.14 ± 1.08, 1.83 ± 1.45, 4.17 ± 3.39, respectively. The values of the PV, PEI, BV of the tumor margin vs. the values of the muscles developed t-values, which were , 10.79, and 5.88, respectively (P 0.01), with statistical significance; the values of the PV, PEI, BV of the tumor center vs. the values of the muscles produced t-values, which were 8.67, 7.49, and 4.55, respectively (P 0.01), with statistical significance. The values of the TTP of the tumor margin vs. TTP values of the muscles, and the TTP values of the tumor center vs. TTP values of the muscles developed t-values, which were 1.7 and 0.806, respectively (P 0.05), without statistical significance. In the patient group, the values of the PV, PE, TTP, and BV of the tumor margin were (88.95 ± 30.89) ml/(min ml), (61.87 ± 27.31) Hu, (37.72 ± 12.53) sec, and (18.38 ± 7.2) ml/100 g, respectively; these values of the tumor center were (39.77 ± 18.29) ml/(min ml), (14.57 ± 8.1) Hu, (35.64 ± 12.41) sec, and (11.22 ± 6.02) ml/100 g, respectively; these values of the muscles were (12.45 ± 6.5) ml/(min ml), (6.14 ± 2.66) Hu, (35.68 ± 12.35) sec, and (2.23 ± 1.11) ml/100 g, respectively. The values
2 366 Clin Oncol Cancer Res (2010) 7: of the RPV, RPEI, and RBV of the tumor margin were 8.05 ± 5.04, 8.87 ± 4.32, and ± 8.49, respectively; these values of the tumor center were 2.39 ± 1.68, 2.97 ± 2.1, 3.53 ± 2.82, respectively. The values of the PV, PEI, BV of the tumor margin in the patient group vs. the values of the muscles produced t-values, which were 13.8, 10.85, and 12.22, respectively (P < 0.01), with significant differences; these values of the tumor center vs. the values of the muscles developed t-values, which were 9.158, 6.26, 8.654, respectively (P < 0.01), with significant differences. The TTP value of the tumor margin vs. that of the muscles produced t-value, which was 0.371, and the TTP value of the tumor center vs. that of the muscles developed t-value, which was 1 (P > 0.05), without statistical difference. CONCLUSION CT perfusion imaging technics demonstrates directly dynamic changes of blood flow to tumors, which assists in identifying tumor growth and necrosis, therefore, this research provides an evidence-based guidelines for the treatment of human lung squamous cell carcinoma and has far-reaching clinical significance. KEY WORDS: perfusion imaging, lung neoplasms, controlled study. Copyright 2010 by Tianjin Medical University Cancer Institute & Hospital and Springer Introduction In recent years, incidence trends of lung cancer have gradually increased. Tumor angiogenesis is the focus for laboratory research and clinical research. With the rapid development of computer technology and evolution in CT technic, multi-slice spiral CT perfusion imaging (CTPI), which evaluates vascular function in tumor has become possible, and in addition, it has also been widely used in the evaluation of liver, brain, and kidney and in the test of abnormal blood flow dynamics [1-3]. In this study, the perfusion parameters obtained from VX2 tumor-bearing rabbits and from human lung squamous carcinoma were compared and evaluated, in order to provide evidence-based clinical treatment for lung cancer patients. Materials and Methods Experimental animals Sixteen New Zealand white rabbits, including male and female, with the average weight of 2.68 kg (ranging from 2-3 kg) were purchased from Experimental Animal Center of Inner Mongolia University (animal certificate: XCXK: M ). All the experimental procedures and animal maintenance were confirmed to the strict guidelines of institutional animal ethics committee. Preparation of tumor-bearing rabbit VX2 squamous cell carcinoma lines were provided by Department of Clinical Laboratory, Peking University Institute of Oncology. The tumor cells were added with normal saline to prepare /ml cell suspension. One rabbit was inoculated subcutaneously 1 ml of cell suspension in its thigh to raise transplantation tumor. After the transplanted tumor formed, it was measured based on the following criteria: the mass could be touched from the surface and felt little mobility and tough quality; removed mass was confirmed by pathologic examination and diagnosed as squamous cell carcinoma. Preparation of rabbit models inoculated with VX2 lung cancer cells (rabbit group) After about 2 weeks of the transplantation, the tumor was removed and cut into little pieces and then made into /ml, 10 ml cell suspension. The other 15 rabbits were injected 0.5 ml/rabbit cell suspension into the lung, guided by CT (Netherlands PHILIPS Brilliance 16-slice spiral CT), and at the 7 th, 14 th, and 21 st day after the injection, CT perfusion imaging was conducted respectively. The standards of successful inoculated rabbit model: CT plain scan showed irregular shadow of soft tissue mass, which could become intensity after enhanced. Patient group Case inclusion criteria: patients aged between 30 and 80 years in Inner Mongolia Baotou Tumor Hospital between October 2009 and May 2010; biopsy showed lung squamous cell carcinoma; informed consents were obtained. Before surgery, all the patients who had undergone CT perfusion imaging, and after the surgery, the specimens were tested by immunohistochemistry (VEGF). Exclusion criteria: squamous cell carcinoma was not confirmed by pathological examination or patients with lung squamous cell carcinoma or their family members refused to participate the study. During the period, 25 patients who met these criteria were collected. There were 16 males and 9 females, and the mean age was 45 years, ranging from years. This study was reviewed and approved by the Institutional Review Board of Inner Mongolia Baotou Tumor Hospital. CT scanning group The experimental rabbits fasted 12 h before the scanning. Right before the canning, the rabbits were given a venous indwelling needle through the ear vein. After that, the rabbits were anesthetized with pentobarbital sodium, of which concentration was 0.1 mmol/l and the dose was 1ml/kg. Then the rabbits were fixed on a board with a supine position. A bellyband was used to
3 367 reduce respiratory motion. Model of the static, samelevel dynamic scanning perfusion was used in the experimental rabbits, in which 3-4 ml of the Iohexol (350 mg/ml), a contrast medium was injected at the speed of 0.4 ml/sec, using binocular high-pressure syringe. One second after the contrast medium was injected, the successive scanning was performed for image acquisition. Patient group Model of the static, same-level dynamic scanning perfusion was applied in human body, in which ml of Iohexol (350 mg/ml) was injected at 3-5 ml/sec, using the binocular high-pressure syringe. One second after the injection, the successive scanning was performed for image acquisition. CT scanning parameters Detector array at mm, slice thickness 3.0 mm, pitch 3.0 mm, tube voltage 120 kv, tube current 100 mas, 360 rotation time 0.4 sec, scan interval 6.5 sec (default minimum). The scanning was repeated times within sec to get a complete dynamic curve, showing the contrast agent circulated in lung cancer. CT perfusion Image processing Special perfusion software and EBW 4.0 Workstation were used for image postprocessing. Region of interest (ROI) The ROI included aorta, tumor margin, tumor center, and the ipsilateral muscle. ROI selection method: at the aorta, tumor margin, tumor center, the ipsilateral muscle of the same cases at the same point PV (perfusion volume), PEI (peak enhanced increment), TTP (transit time to peak), BV (blood volume) were measured. RPV (relative perfusion volume), RPEI (relative peak enhanced increment), RBV (relative blood volume) were calculated using the formula. Main perfusion parameters and the calculation Deconvolution model was used to calculate the values of the main perfusion parameters, PV, PEI, TTP, and BV. Formulas used were: RPV = foci PV/normal muscle PV, RPEI = foci PEI/normal muscle PEI, RBV = foci BV/ normal muscle BV. Generation of perfusion color graph CT perfusion software was applied to get image reformation and to process the false color image. After that, the diagrams of PV, PEI, TTP, BV were employed to evaluate comprehensively the perfusion status in the lesions. Immunohistochemistry Using streptavidin biotin-peroxidase method (SP) to identify CD34. The cytoplasm stain of vascular endothelial cells (VEGF) presented in brown, or brown-yellow color, which was considered that CD34 was positive. VEGF expression was divided into (-) (+++) with a total of 4 levels. Sections were viewed under light microscope at 200 times, and the number of the microvessels, which presented in brown color was counted in 5 different fields. The number of the positive cells < 5% was regarded as negative (-), 5%-25% considered as weak positive (+), 26%-50% regarded as positive (++), > 50% considered as strong positive (+++). Statistical analysis SPSS 13.0 statistical package was used for the statistical analysis. Paired parameters of tumor margin muscle, tumor center, and muscle were analyzed with t-test. P < 0.05 was considered different and P < 0.01 was considered a statistically significant difference. Results CT perfusion parameters of interest regions in the rabbit group Values of the PV, PEI, TTP, and BV in the margin area are presented in Table 1. Values of the RPV, RPEI, and RBV in the margin area are presented in Table 2. The values of PV, PEI, and BV from the tumor margin area vs. the same values from the muscles generated t-values, which were , 10.79, 5.88, respectively, with the P < 0.01, indicating that the differences in the t-values were significant. The values of PV, PEI, and BV of the tumor center vs. the same values of the muscle developed t-values, which were 8.67, 7.49, 4.55, respectively, with the P < 0.01, indicating that the differences in the t-values were significant. TTP of the tumor margin vs. muscle and TTP of the tumor center vs. that of the muscle respectively generated t-values, which were 1.7, 0.806, respectively (P > 0.05). CT perfusion parameters of the interest regions in the patient group The values of RPV, RPEI, and RBV of the tumor margin are presented in Table 4. The values of PV, PEI, and BV of the tumor margin in the patient group vs the values of the muscles developed t-values, which were 13.8, 10.85, (P < 0.01), with statistical differences; these values of the tumor center vs the values of the muscles produced t-values, which were 9.158, 6.26, (P < 0.01), with statistical differences. TTP values of the tumor margin vs. the TTP values of the muscles developed t-values, which was 0.371; TTP values of the tumor center vs the values of the muscles produced t-values, which was 1 (P > 0.05), without statistical difference.
4 368 Clin Oncol Cancer Res (2010) 7: Table 1. Perfusion imaging parameters of the rabbits with VX2 lung tumor. PV [ml/(min ml)] PEI (Hu) TTP (sec) BV (ml/100 g) Tumor margin ± ± ± ± Center ± ± ± ± Muscle ± ± ± ± 2.87 PV = the perfusion values, PEI = peak enhancement increments, TTP = transit time to peak, BV = blood volume Table 2. Relative values of perfusion imaging parameters of the rabbits with VX2 lung tumor. RPV RPEI RBV Lesion edge 4.38 ± ± ± 11.7 Lesion center 2.14 ± ± ± 3.39 Note: RPV = the relative perfusion values, RPEI = relative peak enhancement increments, RBV = relative blood volume Table 4. Relative value of perfusion imaging parameters of different regions of tumor in the patients with squamous cell carcinoma of the lung. RPV RPEI RBV Tumor margin 8.05 ± ± ± 8.49 Tumor center 2.39 ± ± ± 2.82 Note: RPV = the relative perfusion values, RPEI = relative peak enhancement increments, RBV = relative blood volume Table 3. Perfusion imaging parameters of the patients with squamous cell carcinoma of the lung. PV [ml/(min ml)] PEI (Hu) TTP (sec) BV (ml/100 g) Tumor margin ± ± ± ± 7.2 Tumor center ± ± ± ± 6.02 Muscle ± ± ± ± 1.11 PV = the perfusion values, PEI = peak enhancement increments, TTP = transit time to peak, BV = blood volume CT perfusion As the hemodynamic parameters were different in the tumor growing stages, and human lung squamous cell carcinoma also had different pathological grades as tumor grew. For the tumor size of the rabbits larger than 2 cm (Fig.1.1A-1D), its RPV and RPEI from the tumor margin increased gradually, and RBV increased significantly. Its RPV, RPEI, and RBV from the tumor center all decreased. The same values of the moderately differentiated human lung squamous cell carcinoma in the patient group were similar to those values in the rabbit group. Regarding the tumor size of the rabbit group less than 2 cm and no sub-foci appearing in the surrounding tissue of the tumor, its RPV and RPEI of both tumor margin and tumor center were lower, but the RBV of both regions were higher. The same values of the welldifferentiated squamous cell carcinoma of the lung in the patient group were similar to those values in the rabbit group. For the tumor size of the rabbit less than 2 cm and sub-foci appearing in the surrounding tissue of the tumor (Fig.1.2A-2D), its values of RPV, RPEI, and RBV of both tumor center and tumor margin increased significantly. The same values of the poorly differentiated squamous cell carcinoma of the lung in the patient group were similar to those values in the rabbit group. Immunohistochemistry In the rabbit group, lesions smaller than 2 cm were in 7, the lesions larger than 2 cm in 8, and the lesions larger than 2 cm with sub-lesions appearing in the surrounding tissues of the tumor were in 5. VEGF-positive (++) presented in larger size of the tumor (Fig.1.1E). In the patient group, poorly differentiated squamous cell carcinomas were in 12 cases, moderately differentiated squamous cell carcinoma in 8 cases, and well-differentiated squamous cell carcinomas in 5 cases. VEGF-positive (+++) presented in the tumor margin and tumor center of the poorly differentiated lung squamous cell carcinoma (Fig.1.2E). VEGF positive (+++) presented in the tumor margin of the moderately differentiated squamous cell carcinoma. VEGF (+) presented in both rabbits with VX2 lung tumor without appearing sub-foci and well-differentiated squamous cell carcinoma of lung in the patients. VEGF expression was higher in the tumor located in the lung tissue and in the tumor adjacent to bronchi than that of tumor located in the bronchial lu-
5 369 Fig.1. 1A-1D, in the rabbit group, soft tissue mass in the left lung lower lobe shown on the enhanced CT scan was irregular (1A). Perfusion scanning images showed that the parameters of tumor region, PV (1B), PEI (1C), and BV (1D) were significantly higher than those of normal muscle tissue; 2A-2D, in the patient group, poorly differentiated squamous cell carcinoma of the lung, soft tissue mass in the right lung lower lobe shown on the enhanced CT scan was irregular (2A), and swelling hilar lymph nodes also presented on the scan Perfusion scanning images showed that parameters of the tumor area, PV (2B), PEI (2C), and BV (2D) were higher than those of normal muscle tissue, and the sign of circular blood vessels surrounding the tumor could be seen, and enlarged lymph nodes also showed significantly stained; 1E shows the rabbits with VX2 lung tumor, immunohistochemistry showed that the tumor can be seen around the proliferated endothelial cells, which had obvious stain. CD34 immunohistochemistry showed that the tumor blood vessels were stained brown (SP 200); 2E shows the poorly differentiated human lung squamous cell carcinoma immunohistochemistry revealed the proliferated capillaries around the tumor with obvious, stain. CD34 immunohistochemistry showed that the tumor blood vessels were stained brown (SP 200); 3A-5B, the scattered diagram of the perfusion parameters of the rabbit with VX2 lung tumor and the human lung squamous cell carcinoma. The edge RPV scattered diagram (3A) showed normal distribution, and the deviation points indicated poorly differentiated human lung squamous cell carcinoma. The central RPV scattered diagram (3B) demonstrated normal distribution, and deviation points represented well-differentiated human lung squamous cell carcinoma. The edge RPEI scattered diagram (4A) showed a normal distribution and deviation points meant well-differentiated human lung squamous cell carcinoma. The central RPEI scattered diagram (4B) showed a normal distribution. The edge RBV scattered diagram (5A) showed a normal distribution, and the deviation points indicated that the rabbits with VX2 lung tumors had sub-foci. The central RBV scattered diagram (5B) demonstrated normal distribution, and the deviation points meant that the rabbits with VX2 lung tumor developed sub-foci.
6 370 Clin Oncol Cancer Res (2010) 7: men. The lower the differentiation level in histology was, the higher the VEGF expression and MVD were. Discussion With the development of clinical oncology, the introduction of evidence-based medicine, and wide application of new technologies, the clinical diagnosis and treatment of cancer have been required to meet higher standards, therefore, there is an urgent need for more basic research to prove the feasibility of new developed modalities of diagnoses and the treatments. Comparative studies of CT perfusion imaging between the rabbits with VX2 lung tumor and the patients with squamous cell carcinoma of the lung have not been reported in literature to date. Tumor angiogenesis plays an important role in the development, invasion and metastasis of solid tumors, and significantly affects the biological behavior of the tumor and prognosis of the patients [4-6]. The preferred cancer treatment is the targeted therapy (not or less damage to normal tissues), which requires imaging technology to accurately detect and quantificat the angiogenesis. De Keyzer et al. [7] reported that the effectiveness of cancer treatment could be measured by increased necrotic tissue within the tumor and reduced blood perfusion to the tumor. A functional CT can measure perfusion volume and blood volume in the tumor [8] ; CT perfusion imaging can be used to measure physiological parameters of the blood supply to tumor and to other tissues, and these physiological parameters are closely related to the angiogenesis seen under a microscope [9,10]. These parameters can be used to quantitatively analyze the blood supply to the tissues, and the regular evolution of these hemodynamic parameters can be an objective assessment of tumor microcirculation, angiogenesis and the patients early reactions to treatment [11-13]. It is a potential way to identify if the chemotherapy is effective or not in early stage and to help change the treatment schedule so as to get better outcomes [14]. With higher perfusion volume and blood volume in the lung tumor, high grade of malignancy, and extensive angiogenesis in the tumor, the short-term effects of the treatment could be better [15]. Side effects caused by cancer treatment may cause patients suffering severe physical and psychological problems, leading to uncertainties of clinical treatment, therefore, for malignant tumors, relative perfusion parameters (RPV, RPEI, and RBV) of the CT perfusion imaging should be carefully considered. For cancer patients who have developed tolerance to cancer treatments, these parameters can reflect tumor progress and changed microcirculation and angiogenesis in the tumor. Based on the findings reflected by the parameters, individualized treatment plan could be achieved. The research of lung cancer on its occurrence and progress requires people to be the subjects, but for ethical reasons, such experiments are not allowed. Researchers have to establish animal models, being inoculated with human cancer cell lines, which grow the same type of cancer as inoculated cancer cell line, for this kind of research in order to find out the regulation existing in the animal models, which can be extended to humans. A study of cancer treatment led by Samir [16] based on animal model revealed that the law in the development and metastases of the inoculated tumor in animal model is similar to that in human cancer. In this research of CT perfusion imaging on rabbits inoculated with VX2 lung tumor, the same morphology shown by the patients with lung squamous cell carcinoma and by the rabbits with VX2 lung tumor was found and the perfusion parameters of both rabbits with VX2 lung tumor and human lung squamous cell carcinoma were similar. CT perfusion parameters measured from different sizes of tumors in the rabbit group and in the patient group were quantitatively analyzed using paired t-test, and it was found that there were correlations among tumor growth characteristics, pathological types and CT perfusion imaging parameters: (1) When tumor size was less than 2.0 cm, with low grade of malignancy, its RPV and RPEI were all low, but the RBV was higher; with the tumor gradually increased in size, its RPV, RPEI, and RBV were all increased significantly. (2) When the tumor size was larger than 2.0 cm, the RPV and RPEI of the tumor margin were gradually increased, and its RBV was significantly increased, however, the RPV, RPEI, and RBV of the tumor center were decreased. (3) The higher the malignant tumor grade was, the more significant the RPV, RPEI, and RBV of the tumor center and tumor margin were. (4) Moderately differentiated squamous cell carcinoma with the tumor size larger than 2.0 cm, appeared colliquation in tumor center, forming a hollow center, and its RPV and RPEI of the tumor margin were obviously increased, and its RBV was significantly increased. (5) For the tumor occurring in the surrounding tissues of bronchi, its, RPV, RPEI, and RBV of the tumor margin and tumor center were significantly higher than those of the tumor occurring in the bronchial lumen. This research demonstrated that when tumors progressed in the rabbit group and in the patient group, angiogenesis in tumors was increased, and the PV, PEI, and BV of the tumors were accordingly increased, with the increased RPV, RPEI, and PBV. Scattered diagram of the RPV, RPEI, and PBV showed a normal distribution, with a few points off (Fig.1.3A-5B). In the edge RPH scattered diagram of the human lung squamous cell carcinoma, the deviation points showed the poorly differentiated squamous cell carcinoma. In the central RPH scattered diagram, deviation points downward demonstrated well-differentiated squamous cell carcinoma, and the upward deviation points represented moderately differentiated squamous cell carcinoma. In the edge RPEI scattered diagram, the upward deviation points showed poorly differentiated squamous cell carcinoma, and the
7 371 deviation points downward represented well-differentiated squamous cell carcinoma. In the central RPEI scattered diagram, deviation points indicated poorly differentiated squamous cell carcinoma. In the edge RBV scattered diagram, deviation points upward represented poorly differentiated squamous cell carcinoma, and deviation points downward demonstrated well-differentiated squamous cell carcinoma. In the central RPEI scatter diagram of the rabbit group, the deviation points upward meant the tumor size larger than 2 cm, with subfoci around, and the deviation points downward showed that the tumor size was greater than 2 cm and necrosis in the tumor appeared. In the edge RBV scattered diagram, the deviation points upward meant the tumor size larger than 2 cm, with sub-foci around and the deviation points downward represented the tumor size greater than 2 cm, with necrosis in the center. In the central RBV scattered diagram, deviation points indicated the tumor size larger than 2 cm, with multiple sub-foci, which could be associated with the levels of differentiation of malignant tumors, or could be associated with different growth stages of tumors, because the differences in number of microvessels in tumors and in functions that the tumor microvessels behaved correlated to the levels of differentiation and stages of malignant tumors [17,18]. When the malignant levels of tumors were higher, blood perfusion was increased, and the mediastinal and metastatic lymph nodes in the hilar showed enhanced image, with increaased blood perfusion [15]. CT perfusion imaging technics demonstrates directly dynamic changes of blood flow to tumors, which assists in identifying tumor growth and necrosis. Comparative analyses of the perfusion parameters between the rabbits inoculated with VX2 lung tumor and the patients with squamous cell carcinoma of the lung revealed that the laws of tumor growth, microcirculation, and hemodynamics of the rabbits with VX2 lung tumor are similar to those of the patients with lung squamous cell carcinoma. This research of the rabbits with VX2 lung tumor provides an evidence-based guideline for the treatment of human lung squamous cell carcinoma and has farreaching clinical significance. By analysis and evaluation of the perfusion images and perfusion parameters of the rabbits with VX2 lung tumor, the association in the perfusion parameters and the tumor angiogenesis between the experienmental rabbits and the patients with lung sqemous cell carcinoma has been studied in order to establish a non-invasive and effective way to detect tumor blood supply, which is able to exhibit hemodynamic data in tumors during cancer treatments. Conflict of interest statement No potential conflicts of interest were disclosed. References 1 Zhang M, Kono M. Solitary pulmonary nodules: Evaluation of blood flow patterns with dynamic CT. Radiology 1997; 205: Miles KA, Griffiths MR, Fuentes MA, et al. Standardized perfusionvalue: Universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology 2001; 220: Aronen HJ, Gazit IE, Louis DN, et al. Cerbral blood volume map of gliomas: Comparison with tumor grade and histologic. Radiology 1994; 191: Folkman J, Shing Y. Angiogenesis (Review). J Biol Chem 1992; 267: Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147: De Keyzer F, Vandecaveye V, Thoeny H, et al. Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: Evaluation in a rat rhabdomyosarcoma model. Eur Radiol 2009;19: Miles KA. Functional computed tomography in oncology. Eur J Canc 2002; 38: Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review. Eur J Radiol 1999; 30: Miles KA, Charnsangavej C, Lee FT, et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000; 7: Zhou H, Zhang MM, Xiao SX, et al. Dynamic contrastenhanced computed tomogr aphy functional imaging for the evaluation of tumor a ngiogenesis in patients with lung carcinoma. Zhonghua Fang She Xue Za Zhi 2006; 40: (Chinese). 12 Zhang JF, Ren L, Wu J, et al. Investigation of Multi-Slice Spiral CT (MSCT) Perfusion Imaging before and after Transcatheter Arterial Embolization (TAE)in VX2 Soft- Tissue Tumor of. Fang She Xue Shi Jian 2005; 20: (Chinese). 13 Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology 2005; 234: Pickles MD, Lowry M, Manton DJ, et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: Zhang Q, Guo J, Qian HL, et al. Studies on Lung Cancer Angiogenesis Application of Interventional Therapy (A Report of 56 Cases). Chin Clin Oncol 2007; 4: Samir NK, Gregory AC. Animal Models in Developmental Therapeutics. In Holland JF, Kufe DW, Pollock RE et al. (eds): Holland Frei Cancer Medicine. 5th edition. Philadelphia, PA: BC Decker Fontanini G, DeLzurenriis M, Vignati S, et al. Evaluation of epithermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-III a non-small-cell lung cancer: Amphiregulin and microvessel county are independent prognostic indicators of survival. Clin Cancer Res 1998; 4: Dendkamp J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993; 66:
Lung Perfusion Analysis New Pathways in Lung Imaging. Case Study Brochure PLA 309 Hospital
Lung Perfusion Analysis New Pathways in Lung Imaging Case Study Brochure PLA 309 Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2012 all rights reserved. Design and specifications
More informationRadiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh
Radiological staging of lung cancer Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Bronchogenic Carcinoma Accounts for 14% of new cancer diagnoses in 2012. Estimated to kill ~150,000
More informationDeveloping a Statistical Method of Quantifying Vascular Response after Radiotherapy Co-supervised by Dr. Glenn Bauman and Dr.
6 Week Project Developing a Statistical Method of Quantifying Vascular Response after Radiotherapy Co-supervised by Dr. Glenn Bauman and Dr. Slav Yartsev Michal Stankiewicz April 9, 2013 Medical Biophysics,
More informationTitle: Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression
Author's response to reviews Title: Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression Authors: Shu-Hua Ma (mashuhua6699@sina.com)
More informationRadiology Pathology Conference
Radiology Pathology Conference Sharlin Johnykutty,, MD, Cytopathology Fellow Sara Majewski, MD, Radiology Resident Friday, August 28, 2009 Presentation material is for education purposes only. All rights
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationOriginal Article Relation between qualitative and quantitative 3-dimensional ultrasound and ki-67 expression in breast cancer
Int J Clin Exp Med 2015;8(10):18538-18542 www.ijcem.com /ISSN:1940-5901/IJCEM0012561 Original Article Relation between qualitative and quantitative 3-dimensional ultrasound and ki-67 expression in breast
More informationDisclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ???
Disclosures No relevant financial disclosures Diffusion and Perfusion Imaging in the Head and Neck Ashok Srinivasan, MD Associate Professor Director of Neuroradiology University of Michigan Health System
More information1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.
History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12
More informationRESEARCH ARTICLE. Clinical Study of Tumor Angiogenesis and Perfusion Imaging Using Multi-slice Spiral Computed Tomography for Breast Cancer
DOI:http://dx.doi.org/1.7314/APJCP.213.14.1.429 RESEARCH ARTICLE Clinical Study of Tumor Angiogenesis and Perfusion Imaging Using Multi-slice Spiral Computed Tomography for Breast Cancer Na Xu 1&, Zhen
More informationP53 Gene Therapy for Pulmonary Metastasis Tumor from Hepatocellular Carcinoma
P53 Gene Therapy for Pulmonary Metastasis Tumor from Hepatocellular Carcinoma Anti-Cancer Drugs, 2010,21(9):882-884 Miao Yu, Wei Chen, Jinshan Zhang Miao Yu: Department of Department of Interventional
More informationCase Scenario 1: Thyroid
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
More informationCase Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.
Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest
More informationXiaohuan Pan 1,2 *, Xinguan Yang 1,2 *, Jingxu Li 1,2, Xiao Dong 1,2, Jianxing He 2,3, Yubao Guan 1,2. Original Article
Original Article Is a 5-mm diameter an appropriate cut-off value for the diagnosis of atypical adenomatous hyperplasia and adenocarcinoma in situ on chest computed tomography and pathological examination?
More informationDiagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography / computed tomography in fever of unknown origin
175 18 F-FDG PET /CT 1* 2* 1 1 1 1 1 1 1. 100034 2. 100850 18 F-FDG PET /CT fever of unknown origin FUO 2010 8 2013 4 51 FUO FDG PET /CT 3 FDG PET /CT t 51 FUO 32 9 7 3 FDG PET FUO 27 52. 9% 14 27. 5%
More informationRadiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA
Radiation Exposure in Pregnancy John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Illustrative Clinical Scenario 32 year old female 34 weeks pregnant with recent onset shortness of breath and central chest pain
More informationApproach to Pulmonary Nodules
Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and
More informationNew lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma
July 2016 New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma Contributed by: Laurel Rose, MD, Resident Physician, Indiana University School of Medicine,
More informationUpdate on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD
Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Section of Pediatric Radiology C.S. Mott Children s Hospital University of Michigan ethans@med.umich.edu Disclosures No relevant
More informationFunctional aspects of anatomical imaging techniques
Functional aspects of anatomical imaging techniques Nilendu Purandare Associate Professor & Consultant Radiologist Tata Memorial Centre Functional/metabolic/molecular imaging (radioisotope scanning) PET
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationPerfusion Physics. ICMRI2018 March 29-31, 2018 Grand Hilton Hotel, Seoul, Korea. Asian Forum Ⅱ: Perfusion MRI SY24-1.
SY24-1 Perfusion Physics Hiroyuki Kabasawa MR Collaborations and Development, GE Healthcare, Tokyo, Japan Perfusion is referred as the blood supply to micro capillary in tissue. Perfusion parameter such
More informationLung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.
Lung Case Scenario 1 A 54 year white male presents with a recent abnormal CT of the chest. The patient has a history of melanoma, kidney, and prostate cancers. 10/24/13 Chest X-ray: 2.9 cm mass like density
More informationRole of CT imaging to evaluate solitary pulmonary nodule with extrapulmonary neoplasms
Original Research Article Role of CT imaging to evaluate solitary pulmonary nodule with extrapulmonary neoplasms Anand Vachhani 1, Shashvat Modia 1*, Varun Garasia 1, Deepak Bhimani 1, C. Raychaudhuri
More informationImaging of Neuroendocrine Metastases
Imaging of Neuroendocrine Metastases Aoife Kilcoyne, Shaunagh McDermott, Colin McCarthy,Manuel Patino, Dushyant Sahani, Michael Blake Abdominal Imaging Division Massachusetts General Hospital Disclosure
More informationMetastatic mechanism of spermatic cord tumor from stomach cancer
Int Canc Conf J (2013) 2:191 195 DOI 10.1007/s13691-013-0-9 CANCER BOARD CONFERENCE Metastatic mechanism of spermatic cord tumor from stomach cancer Masahiro Seike Yoshikazu Kanazawa Ryuji Ohashi Tadashi
More informationDiffuse high-attenuation within mediastinal lymph nodes on non-enhanced CT scan: Usefulness in the prediction of benignancy
Diffuse high-attenuation within mediastinal lymph nodes on non-enhanced CT scan: Usefulness in the prediction of benignancy Poster No.: C-1785 Congress: ECR 2012 Type: Authors: Keywords: DOI: Scientific
More informationExpression of Thyroid Transcription Factor-1 (TTF-1) in Lung Carcinomas and Its Correlations with Apoptosis and Angiogenesis
16 Clin Oncol Cancer Res (2009) 6: 16~20 DOI 10.1007/s11805-009-0016-z Expression of Thyroid Transcription Factor-1 (TTF-1) in Lung Carcinomas and Its Correlations with Apoptosis and Angiogenesis Xiaoyan
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationCASE REPORT PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE.
PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE. M. Madan 1, K. Nischal 2, Sharan Basavaraj. C. J 3. HOW TO CITE THIS ARTICLE: M. Madan, K. Nischal,
More informationDifferentiation of Benign and Malignant Sub-1-cm Breast Lesions Using Contrast-Enhanced Sonography
ORIGINAL RESEARCH Differentiation of Benign and Malignant Sub-1-cm Breast Lesions Using Contrast-Enhanced Sonography He Liu, MD, Yuxin Jiang, MD, Qing Dai, MD, Qingli Zhu, MD, Liang Wang, MD, Jing Zhang,
More informationPOSITRON EMISSION TOMOGRAPHY (PET)
Status Active Medical and Behavioral Health Policy Section: Radiology Policy Number: V-27 Effective Date: 08/27/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationStaging Colorectal Cancer
Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for
More informationTests Your Pulmonologist Might Order. Center For Cardiac Fitness Pulmonary Rehab Program The Miriam Hospital
Tests Your Pulmonologist Might Order Center For Cardiac Fitness Pulmonary Rehab Program The Miriam Hospital BASIC ANATOMY OF THE LUNGS Lobes of Lung 3 lobes on the Right lung 2 lobes on the Left Blood
More informationLung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09
Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationDetection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma
The Journal of International Medical Research 2012; 40: 293 299 [first published online ahead of print as 40(1) 3] Detection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma
More informationStudy on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value
Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Shen Wei 1,a, Chen Juan 2, Li Xiurong 1 and Yin Jie 1 1 Department of Obstetrics and Gynecology,
More informationWhat Radiologists do?
Multimodality Imaging in Oncology 2018 March 5 th 9th Diagnostic Imaging in Oncology What Radiologists do? Chikako Suzuki, MD, PhD Department of Diagnostic Radiology, KS Solna Department of Molecular Medicine
More informationSpecialist Referral Service Willows Information Sheets. Cancer in cats and dogs: Assessment of the patient
Specialist Referral Service Willows Information Sheets Cancer in cats and dogs: Assessment of the patient Cancer in cats and dogs: Assessment of the patient Cancer is common in human and veterinary medicine.
More informationObject Localization Procedure for Intratumoral Microvessel Density Estimation
Object Localization Procedure for Intratumoral Microvessel Density Estimation OVIDIU GRIGORE ANDRE PUGA Telecommunications and Multimedia Department INESC Porto Praça da Republica 93, 4050-497 Porto PORTUGAL
More informationEstimating Iodine Concentration from CT Number Enhancement
Estimating Iodine Concentration from CT Number Enhancement Rosemary Eaton, Andrew Shah, Jane Shekhdar Medical Physics, Mount Vernon Hospital CT Users Group 4 th October 212, Edinburgh Summary Background
More informationModifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling
Investigations and research Modifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling J. Wang Z. Ying V. Yao L. Ciancibello S. Premraj S. Pohlman
More informationCanadian Scientific Journal. Intraoperative color detection of lymph nodes metastases in thyroid cancer
Canadian Scientific Journal 2 (2014) Contents lists available at Canadian Scientific Journal Canadian Scientific Journal journal homepage: Intraoperative color detection of lymph nodes metastases in thyroid
More informationGUIDELINES FOR CANCER IMAGING Lung Cancer
GUIDELINES FOR CANCER IMAGING Lung Cancer Greater Manchester and Cheshire Cancer Network Cancer Imaging Cross-Cutting Group April 2010 1 INTRODUCTION This document is intended as a ready reference for
More informationPET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
More informationEsophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node
2012 66 5 417 421 Esophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node a b* a a a a a a a b ʼ 418 Horio et al. Acta Med. Okayama Vol.
More informationGROUP 1: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases. Including: Excluding:
GROUP 1: Including: Excluding: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases Solid pulmonary nodules 8mm diameter / 300mm3 volume and BROCK risk of malignancy
More informationAn Update: Lung Cancer
An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology
More informationBreast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina
Breast Imaging: Multidisciplinary Approach Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina No Disclosures Objectives Discuss a multidisciplinary breast
More informationCase Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
More informationPrimary pulmonary cancer colliding with metastatic choriocarcinoma
Case Report Primary pulmonary cancer colliding with metastatic choriocarcinoma Zheng Wang 1, Jingwen Si 2, Jingwei Liu 1 1 Department of Thoracic Surgery, 2 Department of Pathology, Peking University First
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationCustomizing Contrast Injection for Body MDCT: Algorithmic Approach
Customizing Contrast Injection for Body MDCT: Algorithmic Approach Lincoln L. Berland, M.D., F.A.C.R. University of Alabama at Birmingham Before Contrast Prep and Hydration Hydration single most important
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationHepatocellular carcinoma (HCC) is a malignant liver neoplasm
Diagn Interv Radiol 2011; 17:328 333 Turkish Society of Radiology 2011 ABDOMINAL IMAGING ORIGINAL ARTICLE Correlation of dynamic multidetector CT findings with pathological grades of hepatocellular carcinoma
More informationGlossary of Terms Primary Urethral Cancer
Patient Information English Glossary of Terms Primary Urethral Cancer Advanced cancer A tumour that grows into deeper layers of tissue, adjacent organs, or surrounding muscles. Anaesthesia (general, spinal,
More informationPre-operative Ultrasound of Lymph Nodes in Thyroid Cancer
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel
More informationAnatomical and Functional MRI of the Pancreas
Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has
More informationHepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer
More informationONCOLOGY LETTERS 7: , 2014
ONCOLOGY LETTERS 7: 781-786, 2014 Value of multidetector computed tomography in the diagnosis of mucosa associated lymphoid tissue lymphomas in the parotid gland: A case report and review of the literature
More informationCT Chest. Verification of an opacity seen on the straight chest X ray
CT Chest Indications: To assess equivocal plain x-ray findings Staging of lung neoplasm Merastatic workup of extra thoraces malignancies Diagnosis of diffuse lung diseases with HRCT Assessment of bronchietasis
More informationCase Scenario year-old white male presented to personal physician with dyspepsia with reflux.
Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationRole of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective
Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More informationCase Scenario 1 History and Physical 3/15/13 Imaging Pathology
Case Scenario 1 History and Physical 3/15/13 The patient is an 84 year old white female who presented with an abnormal mammogram. The patient has a five year history of refractory anemia with ringed sideroblasts
More informationMonophasic versus biphasic contrast application in CT of patients with head and neck tumour
Monophasic versus biphasic contrast application in CT of patients with head and neck tumour Poster No.: C-3331 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Head and Neck G.
More informationBiomedical Research 2017; 28 (13):
Biomedical Research 2017; 28 (13): 5925-5929 ISSN 0970-938X www.biomedres.info Study on the correlation between ultrasonic imaging features in breast cancer and the expression of ER, PR, HER-2 and nm23.
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationCase Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
More informationIAEA RTC. PET/CT and Planning of Radiation Therapy 20/08/2014. Sarajevo (Bosnia & Hercegovina) Tuesday, June :40-12:20 a.
IAEA RTC PET/CT and Planning of Radiation Therapy Sarajevo (Bosnia & Hercegovina) Tuesday, June 17 2014 11:40-12:20 a.m María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra
More informationLiver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.
New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationStaging and Grading Last Updated Friday, 14 November 2008
Staging and Grading Last Updated Friday, 14 November 2008 There is a staging graph below Blood in the urine is the most common indication that something is wrong. Often one will experience pain or difficulty
More informationStaging Issues: Lung Cancer & Mesothelioma. Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG
Staging Issues: Lung Cancer & Mesothelioma Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG Staging systems Non-Small Cell Lung Cancer (>85%): UICC TNM v6 used until 1.1.10 transition since then to v7
More informationRespiratory Interactive Session. Elaine Borg
Respiratory Interactive Session Elaine Borg Case 1 Respiratory Cytology 55 year old gentleman Anterior mediastinal mass EBUS FNA Case 1 Respiratory Cytology 55 year old gentleman with anterior mediastinal
More informationOriginal Article Analysis of contrast-enhanced ultrasound in the differential diagnosis of papillary thyroid cancer and thyroid nodules
Int J Clin Exp Med 2016;9(7):14424-14429 www.ijcem.com /ISSN:1940-5901/IJCEM0021975 Original Article Analysis of contrast-enhanced ultrasound in the differential diagnosis of papillary thyroid cancer and
More informationCOLORECTAL CARCINOMA
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More informationEmbolotherapy for Cholangiocarcinoma: 2016 Update
Embolotherapy for Cholangiocarcinoma: 2016 Update Igor Lobko,MD Chief, Division Vascular and Interventional Radiology Long Island Jewish Medical Center GEST 2016 Igor Lobko, M.D. No relevant financial
More informationCase Scenario 1: Breast
Case Scenario 1: Breast A 63 year old white female presents with a large mass in her left breast. 4/15/13 Mammogram/US: 1. Left breast mammographic and sonographic at 3:00 measuring 7.1 cm highly suggestive
More informationCase Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue
Case Scenario 1 Oncology Consult: Patient is a 51-year-old male with history of T4N3 squamous cell carcinoma of tonsil status post concurrent chemoradiation finished in October two years ago. He was hospitalized
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationHEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:
HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,
More informationRole of DE-CT in Oncology
Role of DE-CT in Oncology Dushyant Sahani, M.D Director of CT Associate Professor of Radiology Massachusetts General Hospital Harvard Medical School Email-dsahani@partners.org Disclosure Research Grant
More informationPulmonary Nodules & Masses
Pulmonary Nodules & Masses A Diagnostic Approach Heber MacMahon The University of Chicago Department of Radiology Disclosure Information Consultant for Riverain Technology Minor equity in Hologic Royalties
More informationFAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated
Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly
More informationInternational Journal of Current Medical Sciences- Vol. 6, Issue,, pp , June, 2016 A B S T R A C T
ISSN: 2320-8147 International Journal of Current Medical Sciences- Vol. 6, Issue,, pp. 122-126, June, 2016 COMPUTED TOMOGRAPHY IN HEPATIC METASTASES Ananthakumar P and Adaikkappan M., Available online
More informationPET in Rectal Carcinoma
Case Report PET in Rectal Carcinoma Josefina Jofré M 1, Paulina Sierralta C 1, José Canessa G 1,2, Pamela Humeres A 3, Gabriel Castro M 4, Teresa Massardo V 1,4 1 Centro PET de Imágenes Moleculares, Hospital
More informationImaging Decisions Start Here SM
Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan
More informationWhat is Cancer? Understanding the basics of
What is Cancer? Understanding the basics of A process of physical and biological changes that occur when normal healthy cells are transformed into cancer cells What is Cancer? Cancer is an umbrella term
More informationUnusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma
49 Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma Loredana Miglietta a Maria Angela Parodi b Luciano Canobbio b Luca Anselmi c a Medical
More informationNew Horizons in the Imaging of the Lung
New Horizons in the Imaging of the Lung Postprocessing. How to do it and when do we need it? Peter M.A. van Ooijen, MSc, PhD Principal Investigator, Radiology, UMCG Discipline Leader Medical Imaging Informatics
More informationThoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationand Strength of Recommendations
ASTRO with ASCO Qualifying Statements in Bold Italics s patients with T1-2, N0 non-small cell lung cancer who are medically operable? 1A: Patients with stage I NSCLC should be evaluated by a thoracic surgeon,
More informationBronchial carcinosarcoma
Bronchial carcinosarcoma Carolina Carcano 1*, Edward Savage 2, Maria Julia Diacovo 3, Jacobo Kirsch 1 1. Division of Radiology, Cleveland Clinic Florida, Weston, Fl, USA 2. Department of Thoracic and Cardiovascular
More information